Soper KA - Search Results

1

Leydig cell hyperplasia and adenomas in mice treated with finasteride, a 5 alpha-reductase inhibitor: a possible mechanism.

Prahalada S, Majka JA, Soper KA, Nett TM, Bagdon WJ, Peter CP, Burek JD, MacDonald JS, van Zwieten MJ. Prahalada S, et al. Among authors: soper ka. Fundam Appl Toxicol. 1994 Feb;22(2):211-9. doi: 10.1006/faat.1994.1025. Fundam Appl Toxicol. 1994. PMID: 8005373

2

Quantitative evaluation of glandular and stromal compartments in hyperplastic dog prostates: effect of 5-alpha reductase inhibitors.

Laroque PA, Prahalada S, Molon-Noblot S, Cohen SM, Soper K, Duprat P, Peter CP, van Zwieten MJ. Laroque PA, et al. Prostate. 1995 Sep;27(3):121-8. doi: 10.1002/pros.2990270302. Prostate. 1995. PMID: 7567690

3

Qualitative and quantitative evaluation of prostatic histomorphology in rats following chronic treatment with finasteride, a 5-alpha reductase inhibitor.

Prahalada SR, Keenan KP, Hertzog PR, Gordon LR, Peter CP, Soper KA, van Zwieten MJ, Bokelman DL. Prahalada SR, et al. Among authors: soper ka. Urology. 1994 May;43(5):680-5. doi: 10.1016/0090-4295(94)90184-8. Urology. 1994. PMID: 7513109

4

Induction of minisatellite DNA rearrangements by genotoxic carcinogens in mouse liver tumors.

Ledwith BJ, Joslyn DJ, Troilo P, Leander KR, Clair JH, Soper KA, Manam S, Prahalada S, van Zwieten MJ, Nichols WW. Ledwith BJ, et al. Among authors: soper ka. Carcinogenesis. 1995 May;16(5):1167-72. doi: 10.1093/carcin/16.5.1167. Carcinogenesis. 1995. PMID: 7767981

5

Studies of early hepatocellular proliferation and peroxisomal proliferation in Sprague-Dawley rats treated with tumorigenic doses of clofibrate.

Tanaka K, Smith PF, Stromberg PC, Eydelloth RS, Herold EG, Grossman SJ, Frank JD, Hertzog PR, Soper KA, Keenan KP. Tanaka K, et al. Among authors: soper ka. Toxicol Appl Pharmacol. 1992 Sep;116(1):71-7. doi: 10.1016/0041-008x(92)90146-j. Toxicol Appl Pharmacol. 1992. PMID: 1529455

6

Extent and persistence of streptozotocin-induced DNA damage and cell proliferation in rat kidney as determined by in vivo alkaline elution and BrdUrd labeling assays.

Kraynak AR, Storer RD, Jensen RD, Kloss MW, Soper KA, Clair JH, DeLuca JG, Nichols WW, Eydelloth RS. Kraynak AR, et al. Among authors: soper ka. Toxicol Appl Pharmacol. 1995 Dec;135(2):279-86. doi: 10.1006/taap.1995.1234. Toxicol Appl Pharmacol. 1995. PMID: 8545838

7

The relative protective effects of moderate dietary restriction versus dietary modification on spontaneous cardiomyopathy in male Sprague-Dawley rats.

Kemi M, Keenan KP, McCoy C, Hoe CM, Soper KA, Ballam GC, van Zwieten MJ. Kemi M, et al. Among authors: soper ka. Toxicol Pathol. 2000 Mar-Apr;28(2):285-96. doi: 10.1177/019262330002800208. Toxicol Pathol. 2000. PMID: 10805146

8

The heart rate-corrected QT interval of conscious beagle dogs: a formula based on analysis of covariance.

Spence S, Soper K, Hoe CM, Coleman J. Spence S, et al. Toxicol Sci. 1998 Oct;45(2):247-58. doi: 10.1006/toxs.1998.2529. Toxicol Sci. 1998. PMID: 9848132

9

Short-term carcinogenesis bioassay of genotoxic procarcinogens in PIM transgenic mice.

Storer RD, Cartwright ME, Cook WO, Soper KA, Nichols WW. Storer RD, et al. Among authors: soper ka. Carcinogenesis. 1995 Feb;16(2):285-93. doi: 10.1093/carcin/16.2.285. Carcinogenesis. 1995. PMID: 7859360

10

Diet, caloric restriction, and the rodent bioassay.

Keenan KP, Ballam GC, Soper KA, Laroque P, Coleman JB, Dixit R. Keenan KP, et al. Among authors: soper ka. Toxicol Sci. 1999 Dec;52(2 Suppl):24-34. doi: 10.1093/toxsci/52.2.24. Toxicol Sci. 1999. PMID: 10630587

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters